183 related articles for article (PubMed ID: 23530506)
21. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin.
Liu J; Narasimhan P; Yu F; Chan PH
Stroke; 2005 Jun; 36(6):1264-9. PubMed ID: 15890996
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin-mediated neuroprotection in a pediatric mouse model of chronic hypoxia.
Chung E; Kong X; Goldberg MP; Stowe AM; Raman L
Neurosci Lett; 2015 Jun; 597():54-9. PubMed ID: 25899777
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site.
Rössler J; Stolze I; Frede S; Freitag P; Schweigerer L; Havers W; Fandrey J
J Cell Biochem; 2004 Sep; 93(1):153-61. PubMed ID: 15352172
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin and the brain: from neurodevelopment to neuroprotection.
Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Grasso G; Corica F; Frisina N
Clin Sci (Lond); 2002 Sep; 103(3):275-82. PubMed ID: 12193153
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity.
Sinor AD; Greenberg DA
Neurosci Lett; 2000 Sep; 290(3):213-5. PubMed ID: 10963901
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
27. Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases.
Khairallah MI; Kassem LA; Yassin NA; Gamal el Din MA; Zekri M; Attia M
Brain Res Bull; 2016 Mar; 121():148-57. PubMed ID: 26802509
[TBL] [Abstract][Full Text] [Related]
28. Protective action of erythropoietin on neuronal damage induced by activated microglia.
Wenker SD; Chamorro ME; Vittori DC; Nesse AB
FEBS J; 2013 Apr; 280(7):1630-42. PubMed ID: 23384249
[TBL] [Abstract][Full Text] [Related]
29. Molecular biology of erythropoietin.
Jelkmann W
Intern Med; 2004 Aug; 43(8):649-59. PubMed ID: 15468961
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.
Brines ML; Ghezzi P; Keenan S; Agnello D; de Lanerolle NC; Cerami C; Itri LM; Cerami A
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10526-31. PubMed ID: 10984541
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin and Nonhematopoietic Effects.
Nekoui A; Blaise G
Am J Med Sci; 2017 Jan; 353(1):76-81. PubMed ID: 28104107
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities.
Weinreb O; Amit T; Mandel S; Kupershmidt L; Youdim MB
Antioxid Redox Signal; 2010 Sep; 13(6):919-49. PubMed ID: 20095867
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective erythropoietin attenuates microglial activation, including morphological changes, phagocytosis, and cytokine production.
Tamura T; Aoyama M; Ukai S; Kakita H; Sobue K; Asai K
Brain Res; 2017 May; 1662():65-74. PubMed ID: 28257780
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin--a novel concept for neuroprotection.
Sirén AL; Ehrenreich H
Eur Arch Psychiatry Clin Neurosci; 2001 Aug; 251(4):179-84. PubMed ID: 11697582
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin in the brain: can the promise to protect be fulfilled?
Maiese K; Li F; Chong ZZ
Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780
[TBL] [Abstract][Full Text] [Related]
36. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury.
Kato S; Aoyama M; Kakita H; Hida H; Kato I; Ito T; Goto T; Hussein MH; Sawamoto K; Togari H; Asai K
J Neurosci Res; 2011 Oct; 89(10):1566-74. PubMed ID: 21833990
[TBL] [Abstract][Full Text] [Related]
37. Targeting erythropoietin for chronic neurodegenerative diseases.
Chong ZZ; Shang YC; Mu Y; Cui S; Yao Q; Maiese K
Expert Opin Ther Targets; 2013 Jun; 17(6):707-20. PubMed ID: 23510463
[TBL] [Abstract][Full Text] [Related]
38. The molecular biology of erythropoietin.
Lacombe C; Mayeux P
Nephrol Dial Transplant; 1999; 14 Suppl 2():22-8. PubMed ID: 10334664
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin and normal brain development: receptor expression determines multi-tissue response.
Chen ZY; Warin R; Noguchi CT
Neurodegener Dis; 2006; 3(1-2):68-75. PubMed ID: 16909040
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke.
Gonzalez FF; McQuillen P; Mu D; Chang Y; Wendland M; Vexler Z; Ferriero DM
Dev Neurosci; 2007; 29(4-5):321-30. PubMed ID: 17762200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
